A consumer thread
- Thread starter LordSensei1958
- Start date
HSanders
Cracker bitch
This just shows you how stupid most of fashion is. It's all about people wanting to see and be seen with the new hotness. sometimes I like the stuff that's in style but usually I just wear what I like. and I definitely would not be paying no $645 for any shoes.
HSanders
Cracker bitch
CM Punk
Best in the World
I'd never buy a Kia.
Kia's are like the Bic lighters of cars
CM Punk
Best in the World
I've been looking for one since my other site got shut down
Just a heads up for people. I went to check out that site. My anti-virus told me to fuck off cause it's not happening on it's watch. That doesn't mean that there's a definite problem there, because I've got the protections (theoretically) ramped up pretty good when it comes to visiting sites, but I thought I'd pass it on out of an abundance of caution.
HSanders
Cracker bitch
Does your antivirus flag ad plentiful sites? I just opened it in the brave browser and I didn't have a problem.
I don't have a problem with it either.
No.
But like I said, I've got it pretty ramped up, so a specific ad at a specific time would do it. Since it's a real time block, it wouldn't have to be just the site itself, or the site history.
And I'll probably try the site again later, maybe with a different browser or blocker. I just wanted to give out the info I had, in order to let people make an informed decision.
HSanders
Cracker bitch
definitely appreciate the heads up!
A New Personalized Cancer Vaccines Could Finally Defeat Humanity's Greatest Killer:
Scientists are developing personalized cancer vaccines that work by training the immune system to recognize and destroy a patient's unique tumor mutations, also known as neoantigens.
Unlike preventive vaccines, personalized cancer vaccines aim to eliminate leftover cancer cells after treatments like surgery or chemotherapy, which reduces the risk of cancer returning. The challenge lies in selecting the right neoantigens for targeting, triggering a robust immune response, and ensuring patient safety. Recent advancements in cancer biology and technology are making this possible.
Moderna's mRNA-based vaccine, previously successful against melanoma, is now showing encouraging results in treating HPV-negative head and neck cancer. Of the trial participants, 14 saw some level of tumor control, with two experiencing complete remission.
Similarly, a company called Transgene developed a personalized vaccine called TG4050. Combined with surgery and traditional therapies, it resulted in no cancer recurrences in a group of head and neck cancer patients after over a year of follow-up. BioNTech and Genentech also presented positive data on their personalized vaccine targeting pancreatic cancer, a particularly deadly form of the disease.
Of the patients receiving the vaccine, a significant portion showed strong immune response and lower recurrence rates compared to those who didn't receive it. A larger phase 2 trial is underway to confirm these findings. While these early-stage studies offer promising results, personalized cancer vaccines hold the potential to revolutionize cancer treatment.
https://www.facebook.com/photo/?fbi...Sp60wVef-X5Tukanev1wFPKZMnm09b-iI&__tn__=EH-R
Scientists are developing personalized cancer vaccines that work by training the immune system to recognize and destroy a patient's unique tumor mutations, also known as neoantigens.
Unlike preventive vaccines, personalized cancer vaccines aim to eliminate leftover cancer cells after treatments like surgery or chemotherapy, which reduces the risk of cancer returning. The challenge lies in selecting the right neoantigens for targeting, triggering a robust immune response, and ensuring patient safety. Recent advancements in cancer biology and technology are making this possible.
Moderna's mRNA-based vaccine, previously successful against melanoma, is now showing encouraging results in treating HPV-negative head and neck cancer. Of the trial participants, 14 saw some level of tumor control, with two experiencing complete remission.
Similarly, a company called Transgene developed a personalized vaccine called TG4050. Combined with surgery and traditional therapies, it resulted in no cancer recurrences in a group of head and neck cancer patients after over a year of follow-up. BioNTech and Genentech also presented positive data on their personalized vaccine targeting pancreatic cancer, a particularly deadly form of the disease.
Of the patients receiving the vaccine, a significant portion showed strong immune response and lower recurrence rates compared to those who didn't receive it. A larger phase 2 trial is underway to confirm these findings. While these early-stage studies offer promising results, personalized cancer vaccines hold the potential to revolutionize cancer treatment.
https://www.facebook.com/photo/?fbi...Sp60wVef-X5Tukanev1wFPKZMnm09b-iI&__tn__=EH-R
Lord Chevy
I'm home
A New Personalized Cancer Vaccines Could Finally Defeat Humanity's Greatest Killer:
Scientists are developing personalized cancer vaccines that work by training the immune system to recognize and destroy a patient's unique tumor mutations, also known as neoantigens.
Unlike preventive vaccines, personalized cancer vaccines aim to eliminate leftover cancer cells after treatments like surgery or chemotherapy, which reduces the risk of cancer returning. The challenge lies in selecting the right neoantigens for targeting, triggering a robust immune response, and ensuring patient safety. Recent advancements in cancer biology and technology are making this possible.
Moderna's mRNA-based vaccine, previously successful against melanoma, is now showing encouraging results in treating HPV-negative head and neck cancer. Of the trial participants, 14 saw some level of tumor control, with two experiencing complete remission.
Similarly, a company called Transgene developed a personalized vaccine called TG4050. Combined with surgery and traditional therapies, it resulted in no cancer recurrences in a group of head and neck cancer patients after over a year of follow-up. BioNTech and Genentech also presented positive data on their personalized vaccine targeting pancreatic cancer, a particularly deadly form of the disease.
Of the patients receiving the vaccine, a significant portion showed strong immune response and lower recurrence rates compared to those who didn't receive it. A larger phase 2 trial is underway to confirm these findings. While these early-stage studies offer promising results, personalized cancer vaccines hold the potential to revolutionize cancer treatment.
=AZV1WwUhwdg-joSyNg9qyy0nlLKKAi9DzuzMeAy3TgUBvuFwy-nvV_SFUvSsc6-Jv4nEwZcgSmrYKz-ogV17vSb7chf-NgM1yl_zWzhABnyGTvFGWkOqGKt2OmYvsnDofe1xaTxMNri4jDaLjCw86P48B1TlVv8Tsy9yLOB__IvflJVH36mLUXbcjQUK7Bxcz4Ug6yImjUUEvXET70N6gu4utQBPtsV2AiSp60wVef-X5Tukanev1wFPKZMnm09b-iI&__tn__=EH-R]View: https://www.facebook.com/photo/?fbid=1132441955003339&set=a.568782714702602&__cft__[0]=AZV1WwUhwdg-joSyNg9qyy0nlLKKAi9DzuzMeAy3TgUBvuFwy-nvV_SFUvSsc6-Jv4nEwZcgSmrYKz-ogV17vSb7chf-NgM1yl_zWzhABnyGTvFGWkOqGKt2OmYvsnDofe1xaTxMNri4jDaLjCw86P48B1TlVv8Tsy9yLOB__IvflJVH36mLUXbcjQUK7Bxcz4Ug6yImjUUEvXET70N6gu4utQBPtsV2AiSp60wVef-X5Tukanev1wFPKZMnm09b-iI&__tn__=EH-R
Even though big pharma deserves the disdain we feel for it, I have to admire the front line researchers who keep advancing medical boundaries. Things like this, Lasik, smaller MRI machines are just a few.
Similar threads
